Epstein-Barr virus: The first human tumor virus and its role in cancer

Proceedings of the Association of American Physicians

Volumn 111, Issue 6, 1999, Pages 573-580

  Pagano, J S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Burkitt's lymphoma; Cell immortalization; EBV episomes; Epidemiology; Infectious mononucleosis; Nasopharyngeal carcinoma

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; BUTYRIC ACID DERIVATIVE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUCYTOSINE; GANCICLOVIR; METHOTREXATE; PREDNISOLONE; RETINOID; VINCRISTINE;

B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CARCINOGENICITY; EARLY DIAGNOSIS; EPISOME; EPSTEIN BARR VIRUS; GENE THERAPY; HODGKIN DISEASE; IMMUNOTHERAPY; INFECTIOUS MONONUCLEOSIS; LEUKOPLAKIA; NASOPHARYNX CARCINOMA; REVIEW; STOMACH CARCINOMA; T CELL LYMPHOMA; VIRUS INFECTION; VIRUS REACTIVATION;

EID: 0032702969     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.t01-1-99220.x     Document Type: Review

References (24)

1. 1 Rickinson A.B. and Kieff E. Epstein‐Barr virus. In: Virology, 3rd edn. Fields B., Knipe D., Howley P., et al. (eds). Philadelphia: Lippincott‐Raven Publishers, 1996. Pp. 2397–2446.
2. 2 Sixbey J.W., Nedrud J.G., Raab‐Traub N., et al. Epstein‐Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310: 1225 1230, 1984.
3. 3 Niederman J.C., Miller G., Pearson G.A., Pagano J.S. Infectious mononucleosis: Epstein‐Barr virus shedding in saliva and oropharynx. N. Engl. J. Med. 294: 1255 1359, 1976.
4. 4 Sixbey J.W., Lemon S.M., Pagano J.S. A second site for Epstein‐Barr virus shedding: The uterine cervix. Lancet 1: 1122 1124, 1986.
5. 5 Nonoyama M. & Pagano J.S. Separation of Epstein‐Barr virus DNA from large chromosomal DNA in nonvirus‐producing cells. Nature: New Biol. 238: 169 171, 1972.
6. 6 Kieff E. Epstein‐Barr virus and its replication. In: Virology, 3rd edn. Fields B., Knipe D., Howley P., et al. (eds). Philadelphia: Lippincott‐Raven Publishers, 1996. Pp. 2343–2396.
7. 7 Raab‐Traub N. Pathogenesis of Epstein‐Barr virus and its associated malignancies. Semin. Virol. 7: 315 323, 1996.
8. 8 Yoshizaki T., Sato H., Furukawa M., Pagano J.S. The expression of matrix metalloproteinase 9 is enhanced by Epstein‐Barr virus latent membrane protein 1. Proc. Natl. Acad. Sci. U.S.A. 95: 3621 3626, 1998.
9. 9 Pagano J.S. Epstein‐Barr virus: Therapy of active and latent infection. In: Antiviral Chemotherapy. Jeffries D.J. and De Clercq E. (eds). London: John Wiley & Sons, Ltd., 1995. Pp. 155–195.
10. 10 Burkitt D. A children's cancer dependent upon climatic factors. Nature 194: 232 234, 1962.
11. 11 Pagano J.S. The Epstein‐Barr virus and malignancy: Molecular evidence. In: Cold Spring Harbor Symposium on Quantitative Biology: Tumor Viruses. Vol. XXIX. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1975. Pp. 797–805.
12. 12 De The' G. Epidemiology of Epstein‐Barr virus and associated diseases. In: The Herpesviruses. Roizman B. (ed). New York: Plenum Press, 1982. Pp. 25–87.
13. 13 Levitskaya J., Coram M., Levitsky V., et al. Inhibition of antigen processing by the internal repeat region of the Epstein‐Barr virus nuclear antigen‐1. Nature 375: 685 688, 1995.
14. 14 MacMahon E.M.E., Glass J.D., Hayward S.D., et al. Epstein‐Barr virus in AIDS‐related primary central nervous system lymphoma. Lancet 388: 969 973, 1991.
15. 15 Kenney S., Ge J.Q., Westphal E.V., Olsen J. Gene therapy strategies for treating Epstein‐Barr virus‐associated lymphomas: Comparison of two different Epstein‐Barr virus‐based vectors. Hum. Gene Ther. 9: 1131 1141, 1998.
16. 16 Weiss L., Movahed L., Warnke R., Sklar J. Detection of Epstein‐Barr viral genomes in Reed‐Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 320: 502 506, 1989.
17. 17 Harabuchi Y., Yamanaka N., Kataura A., et al. Epstein‐Barr virus in nasal T‐cell lymphomas in patients with lethal mid‐line granuloma. Lancet 1: 128 130, 1990.
18. 18 Cesarman E., Chang Y., Moore P.S., et al. Kaposi's sarcoma‐associated herpesvirus‐like DNA sequences in AIDS‐related body cavity‐based lymphomas. N. Engl. J. Med. 332: 1186 1191, 1995.
19. 19 Sixbey J.W. & Yao Q.Y. Immunoglobulin A‐induced shift of Epstein‐Barr virus tissue tropism. Science 255: 1578 1580, 1992.
20. 20 Webster‐Cyriaque J., Edwards R., Quinlivan E., et al. Epstein‐Barr virus and human herpesvirus 8 prevalence in human immunodeficiency virus‐associated oral mucosal lesions. J. Infect. Dis. 175: 1324 1332, 1997.
21. 21 Shibata D. & Weiss L. Epstein‐Barr virus associated gastric carcinoma. Am. J. Pathol. 140: 769 774, 1992.
22. 22 Lee E., Locker J., Nalesnik M., et al. The association of Epstein‐Barr virus with smooth‐muscle tumors occurring after organ transplantation. N. Engl. J. Med. 332: 19 25, 1995.
23. 23 Pagano J.S., Jimenez G., Sung N.S., et al. Epstein‐Barr viral latency and cell immortalization as targets for antisense oligomers. In: Antisense Strategies. Annals of the New York Academy of Sciences, Volume 660. Baserga R. and Denhardt D.T. (eds). New York: The New York Academy of Sciences, 1992, Pp. 107–116.
24. 24 Rooney C.M., Smith C.A., Brenner M.K., Heslop H.E. Prophylaxis and treatment of Epstein‐Barr virus lymphoproliferative disease using genetically modified cytotoxic T lymphocytes. Lancet 345: 9 13, 1995.